Get the Stockscreener App
244.55
0.71%
1.72
After Hours:
244.54
-0.01
-0.00%
Natera Inc stock is traded at $244.55, with a volume of 1.37M.
It is up +0.71% in the last 24 hours and up +22.32% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$242.83
Open:
$242.22
24h Volume:
1.37M
Relative Volume:
1.05
Market Cap:
$33.75B
Revenue:
$1.96B
Net Income/Loss:
$-253.24M
P/E Ratio:
-128.63
EPS:
-1.9012
Net Cash Flow:
$94.06M
1W Performance:
+2.40%
1M Performance:
+22.32%
6M Performance:
+47.76%
1Y Performance:
+44.69%
1-Day Range:
$239.00
$245.59
1-Week Range:
$233.67
$245.59
52-Week Range:
$125.38
$245.59
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
244.55 | 33.41B | 1.96B | -253.24M | 94.06M | -1.9012 |
|
TMO
Thermo Fisher Scientific Inc
|
572.77 | 216.12B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.25 | 160.43B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.10 | 57.29B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.49 | 41.98B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
225.85 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-27-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-22-25 | Resumed | Wells Fargo | Equal Weight |
| Mar-13-25 | Initiated | RBC Capital Mkts | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Natera acquires Foresight Diagnostics to expand cancer detection capabilities By Investing.com - Investing.com Nigeria
Should Natera’s (NTRA) New Share Offering and Signatera Lymphoma Data Require Action From Investors? - simplywall.st
Dir Chapman Files To Sell 4,366 Of Natera Inc [NTRA] - TradingView
Natera envisions cancer-testing future with $450M Foresight buy - BioWorld MedTech
Boulder diagnostics co. bought by Austin biotech giant in $450M deal - The Business Journals
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
Working capital per share of Natera, Inc. – DUS:45E - TradingView
Natera buys Foresight Diagnostics in $450M cancer testing deal - Fierce Biotech
Austin biotech giant Natera acquires Colorado diagnostics company - The Business Journals
Natera (NASDAQ:NTRA) Hits New 1-Year HighWhat's Next? - MarketBeat
Natera Acquires Foresight Diagnostics - Contract Pharma
ETFs Investing in Natera, Inc. Stocks - TradingView
Natera Acquires Foresight Diagnostics for $275 Million - TipRanks
Natera Completes Foresight Diagnostics Acquisition in All-Stock Deal - marketscreener.com
Natera acquires Foresight Diagnostics - marketscreener.com
Steven Leonard Chapman Sells 4,400 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera, Inc. Earnings and Revenue – GETTEX:45E - TradingView
Net income of Natera, Inc. – GETTEX:45E - TradingView
Natera (NTRA): Assessing Valuation After a Powerful Multi‑Month Share Price Rally - Yahoo Finance
Natera stock reaches all-time high of 241.36 USD - Investing.com
Natera stock reaches all-time high of 241.36 USD By Investing.com - Investing.com Canada
Natera Inc: President Moshkevich sells $714k in stock By Investing.com - Investing.com South Africa
New York State Common Retirement Fund Raises Holdings in Natera, Inc. $NTRA - MarketBeat
XTX Topco Ltd Sells 34,439 Shares of Natera, Inc. $NTRA - MarketBeat
A Look At The Intrinsic Value Of Natera, Inc. (NASDAQ:NTRA) - Yahoo Finance
Edgestream Partners L.P. Grows Stock Position in Natera, Inc. $NTRA - MarketBeat
Arrowstreet Capital Limited Partnership Raises Position in Natera, Inc. $NTRA - MarketBeat
Insider Sell: Solomon Moshkevich Sells 3,000 Shares of Natera In - GuruFocus
Natera Inc: President Moshkevich sells $714k in stock - Investing.com
Natera CEO Chapman sells $1.05 million in stock - Investing.com
Natera CEO Chapman sells $1.05 million in stock By Investing.com - Investing.com UK
Officer Moshkevich Sells 3,000 ($714.5K) Of Natera Inc [NTRA] - TradingView
Natera, Inc.: Revenue and Earnings Analysts Forecasts Revisions | 45E | US6323071042 - marketscreener.com
Natera, Inc.: Dividend historical data and projections - marketscreener.com
Natera (NTRA): Valuation Check After ASH Signatera Lymphoma Data Fuels Hematology Growth Optimism - simplywall.st
NTRA: Double-digit MRD growth, broad Signatera adoption, and new clinical data drive future expansion - TradingView
Natera (NASDAQ: NTRA) to Present 144-Patient Lymphoma Signatera Data at ASH 2025 - Stock Titan
Panagora Asset Management Inc. Grows Stake in Natera, Inc. $NTRA - MarketBeat
Schroder Investment Management Group Reduces Stock Position in Natera, Inc. $NTRA - MarketBeat
Russell Investments Group Ltd. Lowers Position in Natera, Inc. $NTRA - MarketBeat
Hsbc Holdings PLC Trims Stock Position in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Raises Natera (NTRA) Price Target with Overweight Rating | NTRA Stock News - GuruFocus
Morgan Stanley assumes coverage on Natera stock with Overweight rating By Investing.com - Investing.com Nigeria
Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San Antonio Breast Cancer Symposium - Yahoo Finance
Pura Vida Investments LLC Boosts Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Raises Price Target on Natera to $265 From $220, Keeps Overweight Rating - marketscreener.com
Norges Bank Invests $277.75 Million in Natera, Inc. $NTRA - MarketBeat
Korea Investment CORP Boosts Stake in Natera, Inc. $NTRA - MarketBeat
State Board of Administration of Florida Retirement System Buys 4,864 Shares of Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Maintains Natera (NTRA) Overweight Recommendation - MSN
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):